Greiner Bio-One commits to the digitization of pre-analytics

Greiner Bio-One, an influential and innovative global player in the medical biology sector, has been accompanying the changes in this demanding specialty for over sixty years. Identifying the digitization of the pre-analytical phase as a strategic, high value-added challenge, the European company has developed an unprecedented offering with already promising results, as Alain Rave, Managing Director of Greiner Bio-One, and Céline Tomasso, a specialist in its digital solutions, explain.